GemPharmatech Co., Ltd. (SHA:688046)

GemPharmatech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	700.04	686.28	621.73	515.67	392.44	260.45
Other Revenue	0.56	0.56	0.45	0.87	1.34	1.47
Revenue	700.61	686.84	622.19	516.55	393.79	261.92
Revenue Growth (YoY)	9.65%	10.39%	20.45%	31.17%	50.35%	35.91%
Cost of Revenue	271.03	261.33	202.86	150.22	101.27	73.99
Gross Profit	429.57	425.51	419.33	366.33	292.51	187.92
Selling, General & Admin	242.03	239.68	199.61	174.76	134.42	79.43
Research & Development	82.39	87.13	96.6	82.93	55.2	48.22
Other Operating Expenses	6.71	3.57	2.61	1.72	1.59	-36.65
Operating Expenses	334.46	333.68	307.91	267.94	196.11	94.35
Operating Income	95.11	91.83	111.42	98.39	96.4	93.57
Interest Expense	-4.4	-4.3	-2.76	-0.5	-0.74	-0.72
Interest & Investment Income	16.88	22.39	28.65	23.73	14.43	7.91
Currency Exchange Gain (Loss)	1.69	1.69	0.08	1.49	-0.19	-0.76
Other Non Operating Income (Expenses)	-20.42	-21.56	-20.92	-11.32	-16.05	-8.64
EBT Excluding Unusual Items	88.87	90.06	116.48	111.8	93.84	91.35
Gain (Loss) on Sale of Investments	2.28	2.34	2.73	-0.05	0.32	-
Gain (Loss) on Sale of Assets	-0.04	0.01	-0.02	-0.1	0.05	-
Asset Writedown	0.57	-	-	-	-	-
Other Unusual Items	30	26.8	42.1	62.03	49.1	-
Pretax Income	121.68	119.22	161.29	173.68	143.31	91.35
Income Tax Expense	11.36	9.4	2.37	9.02	18.39	14.92
Earnings From Continuing Operations	110.32	109.82	158.91	164.67	124.93	76.43
Net Income	110.32	109.82	158.91	164.67	124.93	76.43
Net Income to Common	110.32	109.82	158.91	164.67	124.93	76.43
Net Income Growth	-29.89%	-30.89%	-3.49%	31.81%	63.45%	152.21%
Shares Outstanding (Basic)	409	407	407	392	357	364
Shares Outstanding (Diluted)	409	407	407	392	357	364
Shares Change (YoY)	-1.73%	-0.18%	3.93%	9.84%	-1.93%	-
EPS (Basic)	0.27	0.27	0.39	0.42	0.35	0.21
EPS (Diluted)	0.27	0.27	0.39	0.42	0.35	0.21
EPS Growth	-28.65%	-30.77%	-7.14%	20.00%	66.67%	-
Free Cash Flow	7.48	-23.36	-89.33	-84.33	24.24	-37.28
Free Cash Flow Per Share	0.02	-0.06	-0.22	-0.21	0.07	-0.10
Dividend Per Share	0.140	0.140	0.160	0.041	-	-
Dividend Growth	-12.50%	-12.50%	290.24%	-	-	-
Gross Margin	61.31%	61.95%	67.40%	70.92%	74.28%	71.75%
Operating Margin	13.58%	13.37%	17.91%	19.05%	24.48%	35.73%
Profit Margin	15.75%	15.99%	25.54%	31.88%	31.72%	29.18%
Free Cash Flow Margin	1.07%	-3.40%	-14.36%	-16.33%	6.16%	-14.23%
EBITDA	174.6	164.62	157.42	135.68	125.2	110.41
EBITDA Margin	24.92%	23.97%	25.30%	26.27%	31.80%	42.15%
D&A For EBITDA	79.49	72.79	46	37.29	28.81	16.83
EBIT	95.11	91.83	111.42	98.39	96.4	93.57
EBIT Margin	13.58%	13.37%	17.91%	19.05%	24.48%	35.73%
Effective Tax Rate	9.34%	7.88%	1.47%	5.19%	12.83%	16.33%
Revenue as Reported	700.61	686.84	622.19	516.55	393.79	-
Advertising Expenses	-	2.93	4.69	8.94	2.87	2.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.